HRSA’s 340B Rebate Pilot Program: Industry Debates, Congressional Response, and Program Implications
A new chapter in the 340B Drug Pricing Program is unfolding as the Health Resources & Services Administration (“HRSA”) pursues its 340B Rebate Model Pilot Program (the “Pilot Program”)—a move ...
One of the world’s biggest drug makers is suing the country’s smallest state. The argument is over a federal drug discount ...
The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize ...
The debate around the U.S. 340B prescription drug discount program is once again heating up in court and in Congress. A day after the American Hospital Association called on the FTC and Department of ...
Letter: Protecting rural health care: why the 340B program is more important than big PhRMA profits.
Disappointed, but not surprised. That was my reaction to the news that two more pharmaceutical groups are suing the state of North Dakota over a new law designed to protect the 340B Drug Pricing ...
The 340B Drug Pricing Program was established in 1992 to benefit low-income and uninsured patients. Three decades later, the program has instead become a backdoor funding mechanism for hospitals and a ...
Does the 340B program need to be updated? Yes. But it needs to be done carefully, with an appreciation of the nuances of the program, its positive impacts and the misuses that have evolved. Physicians ...
The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize the federal government's complex 340B Drug Discount Program. "Trending ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results